[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  DataPorium [@Dataporium_News](/creator/twitter/Dataporium_News) on x XX followers Created: 2025-07-20 07:00:15 UTC 🦠Quest Diagnostics introduced testing for the oropouche virus on July 15, 2025. This new diagnostic lab test addresses an emerging infectious disease linked to severe neurological effects, particularly in South and Central America and the Caribbean. 🧠On July 9, 2025, Quest announced it will offer an FDA-cleared blood test for Alzheimer’s disease this summer. This test expands their AD-detect™ product line, helping to assess symptomatic patients effectively. 📊 Quest Diagnostics released its 2024 Corporate Responsibility Report on June 25, 2025, showcasing its commitment to responsible practices. 📅 The company will announce its second-quarter 2025 financial results on July 22, 2025, before the market opens. 🔬 Additionally, Quest is developing a multi-cancer stratification blood test based on technology from MD Anderson, announced on June 10, 2025. Like and follow us for the latest updates! #DataPorium #QuestDiagnostics #HealthcareInnovation #Diagnostics #AlzheimersResearch At DataPorium, we track the financial performance, product sales, market share, and social network analysis. We also track the trends of nearly XXXXX products every quarter. 🚀 Want to see more? Head over to and explore! 🔗 Visit our X page today for exclusive updates—completely free! XXX engagements  **Related Topics** [united states](/topic/united-states) [testing for](/topic/testing-for) [Post Link](https://x.com/Dataporium_News/status/1946827478133350782)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
DataPorium @Dataporium_News on x XX followers
Created: 2025-07-20 07:00:15 UTC
🦠Quest Diagnostics introduced testing for the oropouche virus on July 15, 2025. This new diagnostic lab test addresses an emerging infectious disease linked to severe neurological effects, particularly in South and Central America and the Caribbean.
🧠On July 9, 2025, Quest announced it will offer an FDA-cleared blood test for Alzheimer’s disease this summer. This test expands their AD-detect™ product line, helping to assess symptomatic patients effectively.
📊 Quest Diagnostics released its 2024 Corporate Responsibility Report on June 25, 2025, showcasing its commitment to responsible practices.
📅 The company will announce its second-quarter 2025 financial results on July 22, 2025, before the market opens.
🔬 Additionally, Quest is developing a multi-cancer stratification blood test based on technology from MD Anderson, announced on June 10, 2025.
Like and follow us for the latest updates!
#DataPorium #QuestDiagnostics #HealthcareInnovation #Diagnostics #AlzheimersResearch
At DataPorium, we track the financial performance, product sales, market share, and social network analysis. We also track the trends of nearly XXXXX products every quarter.
🚀 Want to see more? Head over to and explore!
🔗 Visit our X page today for exclusive updates—completely free!
XXX engagements
Related Topics united states testing for